- Conditions
- Pathology
- Interventions
- Hamamatsu NanoZoomer S360MD Digital Slide Scanner System
- Device
- Lead sponsor
- Hamamatsu Photonics K.K.
- Industry
- Eligibility
- Not listed
- Enrollment
- 540 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 3
- States / cities
- St Louis, Missouri • Cleveland, Ohio • Columbus, Ohio
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Mouth Diseases
- Interventions
- STRATICYTE™ Test
- Other
- Lead sponsor
- Proteocyte Diagnostics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Loma Linda, California • Minneapolis, Minnesota + 1 more
- Conditions
- Cervical Cytology, PAP
- Interventions
- Digital cervical cytology slide imaging system with artificial intelligence (AI) algorithm in vitro diagnostic (IVD) device
- Device
- Lead sponsor
- Techcyte, Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 4,596 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Orem, Utah
- Conditions
- Cancer
- Interventions
- Unaided Review First, Then AI as Double-Check, Then AI as First-Look., Unaided Review First, Then AI as First-Look, Then AI as Double-Check., AI as Double-Check First, Then AI as First-Look, Then Unaided Review., AI as First-Look First, Then AI as Double-Check, Then Unaided Review.
- Behavioral
- Lead sponsor
- Harvard Medical School (HMS and HSDM)
- Other
- Eligibility
- Not listed
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Pathology
- Interventions
- Whole Slide Imaging, Light Microscopy
- Diagnostic Test
- Lead sponsor
- Hamamatsu Photonics K.K.
- Industry
- Eligibility
- Not listed
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 4
- States / cities
- St Louis, Missouri • Albuquerque, New Mexico • Cleveland, Ohio + 1 more